Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Diclazid M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Anthus Pharmaceuticals Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Diclazid M 80mg/500mg Tablet

Metformin/Glimepiride 80mg/500mg tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is only one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular mealtimes and carry a readily available fast-acting glucose source, such as sweets or juice, to counteract hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Diclazid M 80mg/500mg Tablet

No text provided. Please provide the text you wish to be rephrased.

Uses of Diclazid M 80mg/500mg Tablet

Non-insulin-dependent diabetes

Major Benefits of Diclazid M 80mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Diclazid M 80mg/500mg tablets should be administered with a meal.

Common Side effects of Diclazid M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Diclazid M 80mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Diclazid M 80mg/500mg tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Diclazid M 80mg/500mg Tablet works:

Gliclazide and metformin, combined as Diclazid M 80mg/500mg tablets, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Diclazid M 80mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Diclazid M 80mg/500mg tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Diclazid M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose levels are abnormally low or elevated. Refrain from driving should such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Diclazid M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Diclazid M 80mg/500mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Diclazid M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Diclazid M 80mg/500mg Tablet :

Should you forget to take a Diclazid M 80mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Diclazid M 80mg/500mg Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Diclazid M 80mg/500mg Tablet

Diclazid M 80mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances glycemic control when coupled with a healthy diet and regular physical activity. Gliclazide stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose production and increases insulin responsiveness. This medication is unsuitable for individuals with type 1 diabetes.
Diclazid M 80mg/500mg tablets may cause common adverse reactions such as low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use might result in vitamin B12 deficiency.
Indeed, Diclazid M 80mg/500mg tablets may induce hypoglycemia. Low blood sugar symptoms can manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. These symptoms are more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are concurrently used. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is strongly advised.
Diclazid M 80mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon side effect of metformin. Its occurrence is minimized by avoiding use in individuals with kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms potentially indicating lactic acidosis include muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, vomiting, abdominal discomfort, and bradycardia. Should these symptoms appear, discontinue Diclazid M 80mg/500mg tablet use and seek immediate medical attention.
Diclazid M 80mg/500mg tablets may induce vitamin B12 deficiency with prolonged administration. This deficiency arises from the medication's interference with gastric vitamin B12 absorption. Untreated deficiency can lead to anemia, neurological complications including paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. Prophylactic annual supplemental vitamin B12 is recommended by some studies to mitigate these risks.
Patients with hypersensitivity to Diclazid M 80mg/500mg Tablet ingredients or inactive components should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Diclazid M 80mg/500mg tablets and alcohol is unsafe. This combination can lead to dangerously low blood sugar (hypoglycemia) and a heightened risk of lactic acidosis.
Diclazid M 80mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances glycemic control when coupled with a balanced diet and consistent physical activity. Gliclazide stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose production and boosts insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Diclazid M 80mg/500mg tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), altered taste perception, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Rare but potentially severe side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Indeed, Diclazid M 80mg/500mg Tablets may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, a rapid pulse, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Diclazid M 80mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin. Risk is heightened in individuals with kidney impairment, the elderly, and those who consume significant alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Diclazid M 80mg/500mg Tablet use and seek immediate medical attention.
Diclazid M 80mg/500mg Tablet use can lead to vitamin B12 deficiency over extended periods. This deficiency arises from the medication's interference with gastric vitamin B12 absorption. Untreated, this can result in anemia, neurological issues, including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and balance difficulties (ataxia). Preventive measures, suggested by some studies, include annual supplemental vitamin B12 intake.
Patients with hypersensitivity to Diclazid M 80mg/500mg Tablet ingredients or excipients should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment or metabolic acidosis, such as diabetic ketoacidosis.
Combining Diclazid M 80mg/500mg tablets and alcohol is unsafe. This combination can reduce blood sugar to dangerously low levels (hypoglycemia) and raise the risk of lactic acidosis.
Diclazid M 80mg/500mg Tab...
46
MRP 56
18% off